Skip to content

ANI PHARMACEUTICALS, INC: 10-Q filed 2013-11-07

What ANI PHARMACEUTICALS, INC reported in its quarterly report filed 2013-11-07 (fiscal Q3 2013): 39 published measures, 108 facts as tagged in accession 0001144204-13-059427.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-07
Fiscal period
fiscal Q3 2013
Accession
0001144204-13-059427 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ANI PHARMACEUTICALS, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3043,285,828USD
At 2012-12-3113,747,770USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-3036,688,805USD
At 2012-12-31-42,714,495USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-3010,929,806USD
At 2012-12-3111,028USD
At 2012-09-30148,331USD
At 2011-12-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,191,043USD92
2013-01-01 to 2013-09-30-3,131,929USD273
2012-07-01 to 2012-09-30-377,348USD92
2012-01-01 to 2012-09-30-351,234USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-2,619,380USD273
2012-01-01 to 2012-09-30421,605USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-30161,415USD273
2012-01-01 to 2012-09-3076,888USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-07-01 to 2013-09-307,836,222USD92
2013-01-01 to 2013-09-3019,549,670USD273
2012-07-01 to 2012-09-305,036,024USD92
2012-01-01 to 2012-09-3015,049,619USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-4,497,869USD273
2012-01-01 to 2012-09-30-196,386USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-09-30-51,904,465USD
At 2012-12-31-43,798,333USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-3082,852USD92
2013-01-01 to 2013-09-3082,852USD273
2012-07-01 to 2012-09-30866USD92
2012-01-01 to 2012-09-3036,327USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-304,640,487USD
At 2012-12-314,879,173USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-302,951USD273
2012-01-01 to 2012-09-300USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30810,291USD92
2013-01-01 to 2013-09-30-2,561,823USD273
2012-07-01 to 2012-09-30-207,401USD92
2012-01-01 to 2012-09-30974,388USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-3026,094,759USD
At 2012-12-318,566,307USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-300USD92
2013-01-01 to 2013-09-30466,902USD273
2012-07-01 to 2012-09-3081,225USD92
2012-01-01 to 2012-09-301,239,137USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-306,597,023USD
At 2012-12-317,711,082USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-302,086,847USD
At 2012-12-311,993,567USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2013-09-301,838,309USD
At 2012-12-310USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-09-309,515,096USD
At 2012-12-315,432,401USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2013-01-01 to 2013-09-30432,562USD273
2012-01-01 to 2012-09-300USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-09-302,809,160USD
At 2012-12-312,809,685USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2013-07-01 to 2013-09-302,629,119USD92
2013-01-01 to 2013-09-307,066,195USD273
2012-07-01 to 2012-09-302,321,773USD92
2012-01-01 to 2012-09-306,292,377USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,750,734USD92
2013-01-01 to 2013-09-304,261,182USD273
2012-07-01 to 2012-09-301,256,754USD92
2012-01-01 to 2012-09-302,961,649USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-07-01 to 2013-09-30453,897USD92
2013-01-01 to 2013-09-301,187,461USD273
2012-07-01 to 2012-09-30148,650USD92
2012-01-01 to 2012-09-30636,726USD274

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-3089,024,878USD
At 2012-12-311,083,431USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-307,703,387USD
At 2012-12-317,541,972USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-09-303,062,900USD
At 2012-12-312,662,799USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2013-09-3010,712,273USD
At 2012-12-3185,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-09-3012,550,582USD
At 2012-12-31302,290USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-301,338,215USD
At 2012-12-31555,635USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-30957,854USD92
2013-01-01 to 2013-09-30-3,365,118USD273
2012-07-01 to 2012-09-30-379,831USD92
2012-01-01 to 2012-09-30-455,354USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2013-07-01 to 2013-09-301,040,706USD92
2013-01-01 to 2013-09-30-8,256,465USD273
2012-07-01 to 2012-09-30-2,906,530USD92
2012-01-01 to 2012-09-30-4,745,649USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-07-01 to 2013-09-30133,972USD92
2013-01-01 to 2013-09-30400,101USD273
2012-07-01 to 2012-09-30131,459USD92
2012-01-01 to 2012-09-30387,738USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-07-01 to 2013-09-30381,699USD92
2013-01-01 to 2013-09-30672,828USD273
2012-07-01 to 2012-09-30143,959USD92
2012-01-01 to 2012-09-30425,238USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2013-07-01 to 2013-09-30247,727USD92
2013-01-01 to 2013-09-30272,727USD273
2012-07-01 to 2012-09-3012,500USD92
2012-01-01 to 2012-09-3037,500USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-07-01 to 2013-09-30147,563USD92
2013-01-01 to 2013-09-30-336,393USD273
2012-07-01 to 2012-09-30-91,205USD92
2012-01-01 to 2012-09-30-190,605USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-304,082,695USD273
2012-01-01 to 2012-09-30518,429USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-525USD273
2012-01-01 to 2012-09-30387,172USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-3093,280USD273
2012-01-01 to 2012-09-3087,897USD274

Inspect the source

Entity
ANI PHARMACEUTICALS, INC / CIK 0001023024
Captured
2026-09-20T05:13:47.462Z
SEC response SHA-256
73f151e92444492f6e76683dd14e436bd7ae49ff3f0c015ea516484800094ee5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001023024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))